We are live on ! Find out more
CANF icon

Can-Fite BioPharma American Depositary Shares
CANF

5 hedge funds and large institutions have $2.39M invested in Can-Fite BioPharma American Depositary Shares in 2014 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

38,010% more capital inflows, than outflows

Capital inflows: $2.67M | Capital outflows: $7K

400% more funds holding

Funds holding: 1 → 5 (+4)

0.16% more ownership

Funds ownership: 0% → 0.16% (+0.16%)

Holders
5
Holders Change
+4
Holders Change %
+400%
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.66M
2
Deutsche Bank
Deutsche Bank
Germany
+$667K
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$274K
4
Morgan Stanley
Morgan Stanley
New York
+$51.3K
5
UBS
UBS
Switzerland
+$17.1K

Top Sellers

Rank Fund Capital Flow
1
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
-$7K

CANF Hedge Fund Activity: Q1 2014 in Review

5 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q1 2014, worth a combined $2.39M — up 4,590% from $51K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CANF positions and 0 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.66M. The largest seller was Tower Research Capital (TRC), cutting an estimated $7K.

  • 5 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q1 2014, up from 1 in Q4 2013.
  • Funds reported $2.39M of Can-Fite BioPharma American Depositary Shares stock for Q1 2014, up 4,590% quarter-over-quarter.
  • 4 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q1 2014 and 0 closed out, a net change of +4 holders.
  • The largest Can-Fite BioPharma American Depositary Shares buyer in Q1 2014 was Susquehanna International Group, an estimated $1.66M added.
  • The largest Can-Fite BioPharma American Depositary Shares seller in Q1 2014 was Tower Research Capital (TRC), an estimated $7K sold.

Based on aggregated 13F filings for Q1 2014.